Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
The Oncologist|October 27, 2005
Topotecan: weighing in when there are many optionsRichard T Penson, Michael V SeidenAnticancer Research|April 12, 2003
beta tubulin mutations are rare in human ovarian carcinomaDiana E Lamendola, Zhenfeng Duan, Richard T Penson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell linesZhenfeng Duan, Yifei Duan, Diana E Lamendola, et al.Gynecologic Oncology|March 30, 2004
Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samplesRichard T Penson, Esther Oliva, Steven J Skates, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Cone damage in patients receiving high-dose irofulven treatmentMichael S Lee, Nisha Gupta, Richard T Penson, et al.The Journal of Allergy and Clinical Immunology|June 9, 2009
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and managementPaul E Hesterberg, Aleena Banerji, Eyal Oren, et al.The Oncologist|September 24, 2005
Laughter: the best medicine?Richard T Penson, Rosamund A Partridge, Pandora Rudd, et al.Gynecologic Oncology|December 8, 2004
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancerAnna Berkenblit, Michael V Seiden, Ursula A Matulonis, et al.Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.Pageof 18